Prostate Cancer Gene Therapy Clinical Trials
Open Access
- 1 June 2007
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (6) , 1042-1052
- https://doi.org/10.1038/sj.mt.6300162
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Five-year Follow-up of Trial of Replication-competent Adenovirus-mediated Suicide Gene Therapy for Treatment of Prostate CancerMolecular Therapy, 2007
- Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate CancerJournal of Clinical Oncology, 2006
- Second-Generation Replication-Competent Oncolytic Adenovirus Armed with Improved Suicide Genes and ADP Gene Demonstrates Greater Efficacy without Increased ToxicityMolecular Therapy, 2006
- Susceptibility of B lymphocytes to adenovirus type 5 infection is dependent upon both coxsackie–adenovirus receptor and αvβ5 integrin expressionJournal of General Virology, 2005
- Radiation increases the activity of oncolytic adenovirus cancer gene therapy vectors that overexpress the ADP (E3-11.6K) proteinCancer Gene Therapy, 2003
- Phase I Dose Escalation Clinical Trial of Adenovirus Vector Carrying Osteocalcin Promoter-Driven Herpes Simplex Virus Thymidine Kinase in Localized and Metastatic Hormone-Refractory Prostate CancerHuman Gene Therapy, 2003
- Prostate-Specific Antigen Response and Systemic T Cell Activation After In Situ Gene Therapy in Prostate Cancer Patients Failing RadiotherapyHuman Gene Therapy, 2001
- Interleukin 2 Gene Therapy for Prostate Cancer: Phase I Clinical Trial and Basic BiologyHuman Gene Therapy, 2001
- Fractionated radiation therapy in combination with adenoviral delivery of the cytosine deaminase gene and 5-fluorocytosine enhances cytotoxic and antitumor effects in human colorectal and cholangiocarcinoma modelsGene Therapy, 2000
- PROSTATE REBIOPSY IS A POOR SURROGATE OF TREATMENT EFFICACY IN LOCALIZED PROSTATE CANCERJournal of Urology, 1998